Advancements in Lung Cancer Treatment

This chapter explores the complexities of managing lung cancer patients, with an emphasis on the interplay between autoimmune toxicity and treatment benefits. It discusses recent advancements in immunotherapy strategies, including adjuvant and neoadjuvant approaches, as well as the implications of circulating tumor DNA in treatment decision-making. Key comparisons with melanoma treatments, along with evolving perspectives among medical professionals, highlight the potential for improved patient outcomes through tailored therapy.